MedTrace Logo

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

NCT06629636 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-08

No results posted yet for this study

Summary

The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.

Conditions

  • Repeated IVF Failure
  • Female Infertility

Interventions

DIETARY_SUPPLEMENT

NMN capsule

Total of 900mg/day for 8 weeks

OTHER

Placebo

NMN-free placebo capsules for 8 weeks

Sponsors & Collaborators

  • Abinopharm, Inc

    collaborator NETWORK

  • Aba Chemicals Co Ltd

    collaborator UNKNOWN

  • Sunkaky Medical Cooperation

    lead INDUSTRY

Principal Investigators

  • Yoshiharu M., Yoshiharu Morimoto, MD, PhD · Sankaky Medical Corporation

  • Naoharu M., Naoharu Yoshiharu, MD · Sankaky Medical Corporation

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
32 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-20
Primary Completion
2025-09-30
Completion
2026-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06629636 on ClinicalTrials.gov